Your browser doesn't support javascript.
loading
Do Tofacitinib Generics Exhibit Conventional Synthetic Disease-Modifying Anti-rheumatic Drug and Non-steroidal Anti-inflammatory Drug-Sparing Ability in the Management of Axial Spondyloarthritis?
Ganapati, Arvind; Arya, Suvrat; Gupta, Nikhil; Patil, Abhishek; Chebbi, Pramod; Doley, Daisy; Jeevanagi, Sachin R; Sahu, Rahul; Mandal, Santosh K.
Afiliação
  • Ganapati A; General Medicine/Rheumatology, Kasturba Medical College, Manipal, IND.
  • Arya S; Rheumatology and Clinical Immunology, All India Institute of Medical Sciences, Mangalagiri, Guntur, IND.
  • Gupta N; Rheumatology, Jaypee Hospital, Noida, IND.
  • Patil A; Rheumatology, Saroj Super Speciality Hospital, New Delhi, IND.
  • Chebbi P; Rheumatology, Sant Parmanand Hospital, New Delhi, IND.
  • Doley D; Rheumatology, Manipal Hospital, Bengaluru, IND.
  • Jeevanagi SR; Rheumatology, SDM (Shri Dharmasthala Manjunatheshwara) College of Medical Sciences and Hospital, SDM University, Dharwad, IND.
  • Sahu R; Rheumatology, Assam Medical College and Hospital, Dibrugarh, IND.
  • Mandal SK; Rheumatology, Gurusharan Arthritis & Rheumatology Clinic, Kalaburagi, IND.
Cureus ; 15(10): e46391, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37927736
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article